BioSyent Statistics

Total Valuation

BioSyent has a market cap or net worth of CAD 125.58 million. The enterprise value is 110.68 million.

Market Cap	125.58M
Enterprise Value	110.68M

Important Dates

The last earnings date was Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	Feb 28, 2025

Share Statistics

BioSyent has 11.26 million shares outstanding. The number of shares has decreased by -2.98% in one year.

Current Share Class	n/a
Shares Outstanding	11.26M
Shares Change (YoY)	-2.98%
Shares Change (QoQ)	-0.90%
Owned by Insiders (%)	13.90%
Owned by Institutions (%)	17.37%
Float	8.61M

Valuation Ratios

The trailing PE ratio is 18.10 and the forward PE ratio is 13.77.

PE Ratio	18.10
Forward PE	13.77
PS Ratio	3.69
PB Ratio	3.59
P/TBV Ratio	4.17
P/FCF Ratio	14.55
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.37, with an EV/FCF ratio of 12.82.

EV / Earnings	15.22
EV / Sales	3.16
EV / EBITDA	11.37
EV / EBIT	12.05
EV / FCF	12.82

Financial Position

The company has a current ratio of 4.53, with a Debt / Equity ratio of 0.03.

Current Ratio	4.53
Quick Ratio	3.49
Debt / Equity	0.03
Debt / EBITDA	0.11
Debt / FCF	0.12
Interest Coverage	155.25

Financial Efficiency

Return on equity (ROE) is 20.84% and return on invested capital (ROIC) is 15.94%.

Return on Equity (ROE)	20.84%
Return on Assets (ROA)	13.85%
Return on Invested Capital (ROIC)	15.94%
Return on Capital Employed (ROCE)	25.54%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.85
Inventory Turnover	1.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.16% in the last 52 weeks. The beta is 0.85, so BioSyent's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	+28.16%
50-Day Moving Average	11.07
200-Day Moving Average	10.83
Relative Strength Index (RSI)	50.80
Average Volume (20 Days)	3,451

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioSyent had revenue of CAD 35.03 million and earned 7.27 million in profits. Earnings per share was 0.62.

Revenue	35.03M
Gross Profit	27.86M
Operating Income	9.18M
Pretax Income	9.78M
Net Income	7.27M
EBITDA	9.60M
EBIT	9.18M
Earnings Per Share (EPS)	0.62

Full Income Statement

Balance Sheet

The company has 15.94 million in cash and 1.04 million in debt, giving a net cash position of 14.90 million or 1.32 per share.

Cash & Cash Equivalents	15.94M
Total Debt	1.04M
Net Cash	14.90M
Net Cash Per Share	1.32
Equity (Book Value)	35.00M
Book Value Per Share	3.10
Working Capital	19.07M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.66 million and capital expenditures -32,657, giving a free cash flow of 8.63 million.

Operating Cash Flow	8.66M
Capital Expenditures	-32,657
Free Cash Flow	8.63M
FCF Per Share	0.77

Full Cash Flow Statement

Margins

Gross margin is 79.52%, with operating and profit margins of 26.21% and 20.75%.

Gross Margin	79.52%
Operating Margin	26.21%
Pretax Margin	27.93%
Profit Margin	20.75%
EBITDA Margin	27.41%
EBIT Margin	26.21%
FCF Margin	24.64%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.79%.

Dividend Per Share	0.20
Dividend Yield	1.79%
Dividend Growth (YoY)	12.12%
Years of Dividend Growth	3
Payout Ratio	28.61%
Buyback Yield	2.98%
Shareholder Yield	4.77%
Earnings Yield	5.79%
FCF Yield	6.87%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioSyent has an Altman Z-Score of 13.8.

Altman Z-Score	13.8
Piotroski F-Score	n/a